Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-05-01-2005
Volume0
Issue 0

TOC

TOC

External Link - article-162644.pdf

Articles in this issue
Pharm Exec Ad Stars
Elephant or Specialist?
Elephant or Specialist?
i1-162031-1408696243861.jpg
Global Report: Iron Fist
i1-162030-1408696246506.jpg
Washington Report: The Pendulum Swings
i1-162158-1408695976296.jpg
What Does It Take to be a Global Leader in Training
i3_t-162640-1408695466269.jpg
Unleash the Tablets

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Michael Grosberg
Related Content
Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration
August 27th 2025

Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration

Don Tracy, Associate Editor
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 27th 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
Stock.adobe.com
August 27th 2025

Genentech Breaks Ground for New Manufacturing Facility in North Carolina

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 27th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events
August 27th 2025

FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events

Don Tracy, Associate Editor
AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder
August 27th 2025

AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder

Don Tracy, Associate Editor